Literature DB >> 11493312

Psoriasis scales contain C5a as the predominant chemotaxin for monocyte-derived dendritic cells.

U Mrowietz1, W A Koch, K Zhu, O Wiedow, J Bartels, E Christophers, J M Schröder.   

Abstract

Dendritic cells seem to be of major importance for the pathogenesis of psoriasis. They are increased in number in lesional psoriatic skin which is thought to be due to an increased influx from the peripheral blood regulated by chemotaxins. Using a biological/biochemical approach we have addressed the question whether psoriasis scale extracts contain proteinaceous chemotaxins for dendritic cells. Human monocytes differentiated into dendritic cells by culture with GM-CSF and IL-4 (MoDC) served as responder cells. Chemotactic activity for MoDC was purified by several HPLC-steps. The results of our study show that C5a/C5adesarg is the major chemotactic peptide for MoDC in psoriasis scale extracts. In comparison to other stimuli such as fMLP or monocyte chemotactic peptide 1 (MCP-1) C5a proved to be a most potent and efficient chemotaxin for MoDC. C5a co-eluted with MRP14/calgranulin B which is present in large amounts in psoriasis scale extracts as identified by amino acid sequencing. However, MRP14/calgranulin B did not possess any chemotactic activity for MoDC. Our results provide evidence that C5a/C5adesarg although not specific for dendritic cells seems to be the major chemoattractant for these cells in lesional psoriasis skin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11493312     DOI: 10.1034/j.1600-0625.2001.100403.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  7 in total

1.  Up-regulation of C5a receptor expression and function on human monocyte derived dendritic cells by prostaglandin E2.

Authors:  Oliver Weinmann; Ralf Gutzmer; Jörg Zwirner; Miriam Wittmann; Katja Langer; Margarete Lisewski; Susanne Mommert; Alexander Kapp; Thomas Werfel
Journal:  Immunology       Date:  2003-12       Impact factor: 7.397

2.  Complement modulates the cutaneous microbiome and inflammatory milieu.

Authors:  Christel Chehoud; Stavros Rafail; Amanda S Tyldsley; John T Seykora; John D Lambris; Elizabeth A Grice
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-26       Impact factor: 11.205

Review 3.  The role of C5a in acute lung injury induced by highly pathogenic viral infections.

Authors:  Renxi Wang; He Xiao; Renfeng Guo; Yan Li; Beifen Shen
Journal:  Emerg Microbes Infect       Date:  2015-05-06       Impact factor: 7.163

4.  Complement C3 Exacerbates Imiquimod-Induced Skin Inflammation and Psoriasiform Dermatitis.

Authors:  Chiara Giacomassi; Norzawani Buang; Guang Sheng Ling; Greg Crawford; H Terence Cook; Diane Scott; Francesco Dazzi; Jessica Strid; Marina Botto
Journal:  J Invest Dermatol       Date:  2016-11-19       Impact factor: 8.551

Review 5.  Complement Activation in Inflammatory Skin Diseases.

Authors:  Jenny Giang; Marc A J Seelen; Martijn B A van Doorn; Robert Rissmann; Errol P Prens; Jeffrey Damman
Journal:  Front Immunol       Date:  2018-04-16       Impact factor: 7.561

6.  Serum lipid metabolism in psoriasis and psoriatic arthritis - an update.

Authors:  Aldona Pietrzak; Paweł Chabros; Ewelina Grywalska; Paweł Kiciński; Kinga Pietrzak-Franciszkiewicz; Dorota Krasowska; Grzegorz Kandzierski
Journal:  Arch Med Sci       Date:  2018-03-08       Impact factor: 3.318

Review 7.  The role of dendritic cells in the immunopathogenesis of psoriasis.

Authors:  Sunit P Jariwala
Journal:  Arch Dermatol Res       Date:  2007-08-07       Impact factor: 3.017

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.